Ion exchange resins: Drug delivery and therapeutic applications

Fabad Journal of Pharmaceutical Sciences

Volumn 32, Issue 2, 2007, Pages 91-100

  Singh, Inderbir ^a   Rehni, Ashish K ^a   Kalra, Rohit ^a   Joshi, Gaurav ^a   Kumar, Manoj ^a   Aboul Enein, Hassan Y ^b  

^a CHITKARA UNIVERSITY   (India)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Exchangeable ion; Ion exchange resins; Modified release; Taste masking

Indexed keywords

EID: 77952907581     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Kasture AV Wadodkar SG, Mahadik KK, More HN. A Textbook of Pharmaceutical Analysis and Instrumental Methods. 8th ed., Pierce Scientific, Rockford,IL,USA 2002. p. 39-47.
2. Bhalekar M, Avari JG, Jaiswal SB. Cation-exchanger in pharmaceutical formulation. Ind J Pharm Sci 38(4): 184-187, 2004.
3. Chen L, Yang G, Zhang J. A study of the exchange kinetics of ion exchange fiber. React Funct Polym 29: 139-144, 1996. (Pubitemid 126375364)
4. Aboul-Enein HY, Al-Durabi IA. Separation of several free polyamines and their acetylated derivatives by ionpair reversed-phase high performance liquid chromatography. Biomed Chromatogr. 12(5): 291-293, 1998.
5. Hughes L (2004). Ion exchange resin unique solution to formulation problem; pharmaceutical technology excipients and solid dosage form. www.pharmtech.com
6. Jain NK. Advanced Drug Delivery System. 1st ed.,Aantares Pharma,NJ,USA 2005. p. 290-302.
7. Borodkin SS, Swarbrick J, Boylon CJ. Encyclopedia of Pharmaceutical Technology. Vol. 8. New York: Marcel Dekker, Inc.; 1995. p. 203-310.
8. Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 30: 429-448, 2004. (Pubitemid 38821855)
9. Roy G. General ingredient or process approaches to bitterness inhibition and reduction in oral pharmaceuticals. In: Roy G, editor. Modifying Bitterness: Mechanisms, Ingredients and Applications. Lancaster, PA: Technomic Publishing; 1997. p. 285-320.
10. Bhise K, Shaikh S, Bora D. Taste mask, design and evaluation of an oral formulation using ion exchange resin as drug carrier. AAPS Pharm Sci Tech 9(2): 557-562, 2008.
11. Madgulkar AR, Bhalekar MR, Patel KG, Wable ND, Kolhe VJ. Comparative evaluation of taste masking methods for fexofenadine HCl. The Pharma Review Oct-Nov: 176-180, 2007.
12. Chaudhari PD, Kolhe SR, Chaudhari SP, More DM. Use of cation exchange resins to optimize the taste masking of bitter drug Rizatriptan benzoate. Indian Drugs 43(10): 795-799, 2006.
13. Jane VC, Giovanna M, David PC. Masking the taste of the conditioned taste aversion agent levamisole using an ion exchange resin, for practical application in wildlife management. Pest Management Sci 62: 120-125, 2006.
14. Sambaji P, Rana Z, Pradeep N, Kakasaheb M, Shivajirao K. Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS Pharm Sci Tech 5(4): article 62, 2004.
15. Agarwal R, Mittal R, Singh A. Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev Ind Pharm 26(7): 773-776, 2000. (Pubitemid 30397333)
16. Hughes L. New uses of ion exchange resins in pharmaceutical formulations. www.rohmhaas.com.
17. Chaubal MV. Synthetic polymer-based ion exchange resins: excipients & actives. Drug Del Tech 3(5): 6-8, 2003.
18. Kankkunen T, Huupponen I, Lahtinen K, Sundell M, Ekman K, Kontturi K, Hirvonen J. Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis. Eur J Pharm Sci 16(4-5): 273-280, 2002.
19. Purnima A, Namita P, Anita W. Indion 414 as superdisintegrant in formulation of mouth dissolve tablets. Indian J Pharm Sci 68(1): 117-119, 2006.
20. Junyaprasert VB, Manwiwattanakul G. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions. Int J Pharm 352(1-2): 81-91, 2008.
21. Hänninen K, Kaukonen AM, Kankkunen T, Hirvonen J. Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions. J Control Release 91(3): 449-463, 2003.
22. Sriwongjanya M, Bodmeier R. Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm 46(3): 321-327, 1998.
23. Jeong SH, Park K. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. Int J Pharm 353(1-2): 195-204, 2008.
24. Halder A, Sa B. Sustained release of propranolol hydrochloride based on ion-exchange resin entrapped within polystyrene microcapsules. J Microencapsul 23(8): 899-911, 2006. (Pubitemid 46332101)
25. Steel JC, Cavanagh HM, Burton MA, Dingwall D, Kalle WH. In-vitro evaluation of ion-exchange microspheres for the sustained release of liposomal-adenoviral conjugates. J Control Release 95(3): 601-611, 2004. (Pubitemid 38340509)
26. Jeong SH, Berhane NH, Haghighi K, Park K. Drug release properties of polymer coated ion-exchange resin complexes: experimental and theoretical evaluation. J Pharm Sci 96(3): 618-632, 2007. (Pubitemid 46466083)
27. Cheng YH, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj NF, Smith A, Davis SS, Illum L. Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J Control Release 79(1-3): 243-254, 2002. (Pubitemid 34164177)
28. Higaki M, Takase T, Igarashi R, Suzuki Y, Aizawa C, Mizushima Y. Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin. Vaccine 16(7): 741-745, 1998.
29. Yu L, Li S, Yuan Y, Dai Y, Liu H. The delivery of ketoprofen from a system containing ion-exchange fibers. 319(1-2): 107-113, 2006.
30. Jani R, Gan O, Ali Y, Rodstrom R, Hancock S. Ion exchange resins for ophthalmic delivery. J Ocul Pharmacol 10: 57-67, 1994.
31. Moreau JM, Green LC, Engel LS, Hill JM, O'Callaghan RJ. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. Curr Eye Res 17(8): 808-812, 1998.
32. Tatsuya S, Kenzo O, Yoshimasa I, Noriaki M, Kentaro W, Shoko F, Hiroko Y, Motoshi O, Kazunari S, Yoshiaki K, Hiroshi N. Colestimide lowers plasma glucose levels and increases plasma glucagon-like peptide-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia. J Nippon Med Sch 74(5): 338-343, 2007.